SE9201076L - Användningen av gamla läkemedel för behandling av diabetes - Google Patents
Användningen av gamla läkemedel för behandling av diabetesInfo
- Publication number
- SE9201076L SE9201076L SE9201076A SE9201076A SE9201076L SE 9201076 L SE9201076 L SE 9201076L SE 9201076 A SE9201076 A SE 9201076A SE 9201076 A SE9201076 A SE 9201076A SE 9201076 L SE9201076 L SE 9201076L
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- diabetes
- ring
- sec
- bonded
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201076A SE9201076L (sv) | 1992-04-06 | 1992-04-06 | Användningen av gamla läkemedel för behandling av diabetes |
AU39131/93A AU667362B2 (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for treatment of diabetes |
HU9402854A HUT69710A (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for preparing pharmaceutical compositions suitable for treatment of diabetes |
US08/313,302 US5594005A (en) | 1992-04-06 | 1993-03-31 | Use of quinoline-3-carboxamide compounds for treatment of diabetes |
JP5517372A JPH07506568A (ja) | 1992-04-06 | 1993-03-31 | 糖尿病治療のための既存の薬剤の使用 |
PCT/SE1993/000272 WO1993019756A1 (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for treatment of diabetes |
CA002131831A CA2131831C (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for treatment of diabetes |
NZ251494A NZ251494A (en) | 1992-04-06 | 1993-03-31 | Use of quinoline-3-carboxamide derivatives for the preparation of medicaments for treating diabetes |
EP93908245A EP0634931A1 (en) | 1992-04-06 | 1993-03-31 | The use of quinoline-3-carboxamide compounds for treatment of diabetes |
IL105285A IL105285A0 (en) | 1992-04-06 | 1993-04-02 | Compositions for the treatment of diabetes |
PH45991A PH30820A (en) | 1992-04-06 | 1993-04-02 | Use of quinoline-3-carboxamide compounds for treatment of diabetes. |
CN93105195A CN1081671A (zh) | 1992-04-06 | 1993-04-05 | 使用已知药治疗糖尿病 |
ZA932450A ZA932450B (en) | 1992-04-06 | 1993-04-05 | Drugs for the treatment of diabetes |
NO943723A NO943723D0 (no) | 1992-04-06 | 1994-10-05 | Anvendelse av kinolin-3-karboksamidforbindelser for behandling av diabetes |
KR1019940703534A KR950700738A (ko) | 1992-04-06 | 1994-10-06 | 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes) |
EE9400269A EE03090B1 (et) | 1992-04-06 | 1994-11-17 | Kinoliin-3-karboksamiidühendite kasutamine kompositsiooni valmistamiseks I tüüpi suhkurtõve raviks |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201076A SE9201076L (sv) | 1992-04-06 | 1992-04-06 | Användningen av gamla läkemedel för behandling av diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9201076D0 SE9201076D0 (sv) | 1992-04-06 |
SE9201076L true SE9201076L (sv) | 1993-10-07 |
Family
ID=20385863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE9201076A SE9201076L (sv) | 1992-04-06 | 1992-04-06 | Användningen av gamla läkemedel för behandling av diabetes |
Country Status (16)
Country | Link |
---|---|
US (1) | US5594005A (xx) |
EP (1) | EP0634931A1 (xx) |
JP (1) | JPH07506568A (xx) |
KR (1) | KR950700738A (xx) |
CN (1) | CN1081671A (xx) |
AU (1) | AU667362B2 (xx) |
CA (1) | CA2131831C (xx) |
EE (1) | EE03090B1 (xx) |
HU (1) | HUT69710A (xx) |
IL (1) | IL105285A0 (xx) |
NO (1) | NO943723D0 (xx) |
NZ (1) | NZ251494A (xx) |
PH (1) | PH30820A (xx) |
SE (1) | SE9201076L (xx) |
WO (1) | WO1993019756A1 (xx) |
ZA (1) | ZA932450B (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
US6133285A (en) * | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
FR2827600A1 (fr) * | 2001-07-20 | 2003-01-24 | Lipha | Derives acides de quinolone et leurs applications en therapeutique |
US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
US8653143B2 (en) * | 2008-10-09 | 2014-02-18 | Newtree Co., Ltd. | Use of panduratin derivative or Boesenbergia pandurata extract |
RU2013120556A (ru) | 2010-10-14 | 2014-11-20 | Иммунар Аб | 1,2-гидрокси-2-оксо-хинолин-3-карбоксанилиды в качестве активаторов ahr |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1034124A (en) * | 1973-05-11 | 1978-07-04 | Ciba-Geigy Ag | Process for the manufacture of new quinolines |
FR2340735A1 (fr) * | 1976-02-11 | 1977-09-09 | Roussel Uclaf | Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament |
IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
DE3134780A1 (de) * | 1981-09-02 | 1983-03-10 | Hoechst Ag, 6000 Frankfurt | "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung" |
US5310913A (en) * | 1989-06-09 | 1994-05-10 | Kabi Pharmacia Aktiebolag | Derivatives of quinoline-3-carboxanilide |
SE9000624D0 (sv) * | 1990-02-22 | 1990-02-22 | Pharmacia Ab | New use |
SE9001111D0 (sv) * | 1990-03-27 | 1990-03-27 | Pharmacia Ab | Supportive use |
-
1992
- 1992-04-06 SE SE9201076A patent/SE9201076L/xx not_active Application Discontinuation
-
1993
- 1993-03-31 AU AU39131/93A patent/AU667362B2/en not_active Ceased
- 1993-03-31 CA CA002131831A patent/CA2131831C/en not_active Expired - Fee Related
- 1993-03-31 JP JP5517372A patent/JPH07506568A/ja active Pending
- 1993-03-31 WO PCT/SE1993/000272 patent/WO1993019756A1/en not_active Application Discontinuation
- 1993-03-31 NZ NZ251494A patent/NZ251494A/en unknown
- 1993-03-31 EP EP93908245A patent/EP0634931A1/en not_active Withdrawn
- 1993-03-31 HU HU9402854A patent/HUT69710A/hu unknown
- 1993-03-31 US US08/313,302 patent/US5594005A/en not_active Expired - Fee Related
- 1993-04-02 PH PH45991A patent/PH30820A/en unknown
- 1993-04-02 IL IL105285A patent/IL105285A0/xx unknown
- 1993-04-05 CN CN93105195A patent/CN1081671A/zh active Pending
- 1993-04-05 ZA ZA932450A patent/ZA932450B/xx unknown
-
1994
- 1994-10-05 NO NO943723A patent/NO943723D0/no unknown
- 1994-10-06 KR KR1019940703534A patent/KR950700738A/ko not_active Application Discontinuation
- 1994-11-17 EE EE9400269A patent/EE03090B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2131831C (en) | 1999-03-09 |
KR950700738A (ko) | 1995-02-20 |
HU9402854D0 (en) | 1995-01-30 |
JPH07506568A (ja) | 1995-07-20 |
ZA932450B (en) | 1993-10-20 |
NZ251494A (en) | 1997-07-27 |
NO943723L (no) | 1994-10-05 |
PH30820A (en) | 1997-10-17 |
SE9201076D0 (sv) | 1992-04-06 |
CA2131831A1 (en) | 1993-10-14 |
AU667362B2 (en) | 1996-03-21 |
CN1081671A (zh) | 1994-02-09 |
HUT69710A (en) | 1995-09-28 |
WO1993019756A1 (en) | 1993-10-14 |
NO943723D0 (no) | 1994-10-05 |
AU3913193A (en) | 1993-11-08 |
IL105285A0 (en) | 1993-08-18 |
EE03090B1 (et) | 1998-06-15 |
EP0634931A1 (en) | 1995-01-25 |
US5594005A (en) | 1997-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1889392A (en) | Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles | |
DE69325662D1 (de) | Dopamin rezeptor subtyp liganden | |
HU9302762D0 (en) | N-sulfonyl-2-oxoindole derivatives being effective on vasopressin and/or oxitocin receptors | |
UA66864C2 (uk) | Похідні сечовини, фармацевтична композиція і спосіб лікування або профілактики запальних, аутоімунних або респіраторних захворювань | |
BG101112A (en) | The use of heterocyclic compounds | |
FR2714378B1 (fr) | Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant. | |
EP1652839A3 (en) | Drug efflux pump inhibitor | |
SE9201478D0 (sv) | Heteroaromatic quinuclidinenes, their use and preparation | |
SE9102909D0 (sv) | New use | |
SE9201076L (sv) | Användningen av gamla läkemedel för behandling av diabetes | |
DK0460488T3 (da) | Svovlholdige heterocykliske forbindelser | |
DE69328165D1 (de) | Neue piperazincarboxamide | |
SE9400809D0 (sv) | New use of quinoline-3-carboxamide compounds | |
NO870423L (no) | 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter. | |
SE9400810D0 (sv) | New use of Quinoline-3-carboxamide compounds | |
ATE88634T1 (de) | Arzneimittel zur behandlung von herzinsuffizienz. | |
AU5819294A (en) | N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders | |
DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
FR2651348B1 (xx) | ||
YU49004B (sh) | LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9201076-8 |